Brazil vs Korea: Avoidable mortality
Avoidable mortality over time
- Brazil
- Korea
How they compare
Brazil currently reports 608,011 Deaths against 85,016 Deaths in Korea, a difference of 522,995 Deaths.
That makes Brazil's figure about 7.2 times Korea's.
Across all 24 years both countries report, Brazil has been ahead every year.
Brazil ranks 2nd and Korea ranks 2nd of 36 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 483,011 Deaths | 113,109 Deaths | 369,903 Deaths | Brazil |
| 2010s | 557,051 Deaths | 90,899 Deaths | 466,152 Deaths | Brazil |
| 2020s | 705,252 Deaths | 85,142 Deaths | 620,110 Deaths | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Brazil or Korea?
- Brazil, at 608,011 Deaths against 85,016 Deaths in Korea as of 2023.
- What is the difference in avoidable mortality between Brazil and Korea?
- 522,995 Deaths, with Brazil ahead.
- How many years of comparable data are there for Brazil and Korea?
- 24 years are reported by both, from 2000 to 2023.
- How do Brazil and Korea rank globally for avoidable mortality?
- Brazil ranks 2nd and Korea ranks 2nd of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.